Identifying new potential in cancer-killing T cells

by Kate Ledger,Mayo ClinicGraphical illustration of a general role of ME1 in resilient CD8+T cells. Credit:Science Advances(2023). DOI: 10.1126/sciadv.adi2414When Joanina Gicob

Updated on: January 25,2024

Identifying new potential in cancer-killing T cells

by Kate Ledger,Mayo ClinicGraphical illustration of a general role of ME1 in resilient CD8+T cells. Credit:Science Advances(2023). DOI: 10.1126/sciadv.adi2414When Joanina Gicob

Updated on:January 25,2024

Treatment for recurrent uterine cancer advances to next research phase

by Yale Cancer Center/Smilow Cancer HospitalCredit: Pixabay/CC0 Public DomainThe latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanc

Updated on: August 27,2024

Treatment for recurrent uterine cancer advances to next research phase

by Yale Cancer Center/Smilow Cancer HospitalCredit: Pixabay/CC0 Public DomainThe latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanc

Updated on:August 27,2024

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on: May 07,2024

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on:May 07,2024

Online tool helps ovarian cancer patients feel more in control of symptoms

by University of PittsburghCredit: Unsplash/CC0 Public DomainAn online symptom management tool that harnesses the problem-solving benefits of expressive writing could help women with ovarian canc

Updated on: April 03,2024

Online tool helps ovarian cancer patients feel more in control of symptoms

by University of PittsburghCredit: Unsplash/CC0 Public DomainAn online symptom management tool that harnesses the problem-solving benefits of expressive writing could help women with ovarian canc

Updated on:April 03,2024

Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i

Updated on: December 25,2023

Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i

Updated on:December 25,2023

Could the zika virus fight the brain cancer that killed john McCain?

by E.j. Mundell, Healthday Reporter(HealthDay)—Preliminary research in mice suggests that the Zika virus might be turned from foe into friend—enlisted to curb deadly glioblastoma brain tumors.A gliobl

Updated on: April 18,2024

Could the zika virus fight the brain cancer that killed john McCain?

by E.j. Mundell, Healthday Reporter(HealthDay)—Preliminary research in mice suggests that the Zika virus might be turned from foe into friend—enlisted to curb deadly glioblastoma brain tumors.A gliobl

Updated on:April 18,2024

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

Updated on: April 09,2024

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

Updated on:April 09,2024

Long-term pancreatic cancer survivors report excellent post-surgery quality of life

by Chloe Corey,Mayo ClinicCredit: Mayo Clinic News NetworkPancreatic cancer is considered the most lethal cancer in the human body. But new treatment advances are improving outcomes for patients

Updated on: February 18,2024

Long-term pancreatic cancer survivors report excellent post-surgery quality of life

by Chloe Corey,Mayo ClinicCredit: Mayo Clinic News NetworkPancreatic cancer is considered the most lethal cancer in the human body. But new treatment advances are improving outcomes for patients

Updated on:February 18,2024

Engineered peptides open new avenue for immunotherapy drug development

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cance

Updated on: May 14,2024

Engineered peptides open new avenue for immunotherapy drug development

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cance

Updated on:May 14,2024

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,

Updated on: January 15,2024

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,

Updated on:January 15,2024

Killer T cells get better with age, study finds

by Claudia Ehrlich, Universität des SaarlandesDr. Annette Lis (R) and Dorina Zöphel (L) of Saarland University are studying how the activity of killer cells changes as the cells age. Credit: Oliver Di

Updated on: January 23,2024

Killer T cells get better with age, study finds

by Claudia Ehrlich, Universität des SaarlandesDr. Annette Lis (R) and Dorina Zöphel (L) of Saarland University are studying how the activity of killer cells changes as the cells age. Credit: Oliver Di

Updated on:January 23,2024

Radiologists could soon be using AI to detect brain tumors

byOxford University PressCredit: Anna Shvets from PexelsA paper titled "Deep Learning and Transfer Learning for Brain Tumor Detection and Classification" published inBiology Meth

Updated on: November 23,2024

Radiologists could soon be using AI to detect brain tumors

byOxford University PressCredit: Anna Shvets from PexelsA paper titled "Deep Learning and Transfer Learning for Brain Tumor Detection and Classification" published inBiology Meth

Updated on:November 23,2024